Journal metric profile

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor, five-year Impact Factor, quartile, category rank, publisher, identifiers and citation profile for the 2025 metric year.

JCR-based Impact Factor 2.000 2025 metric year
5-Year Impact Factor 2.300 Longer citation window
JCR Quartile Q3 Subject-category quartile
JCR Category Rank 57/98 Recorded category rank

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS JCR impact factor overview

This profile summarizes the journal metrics and publication information available in the current directory record.

Page reviewed August 6, 2026

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS metric snapshot

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS has a bibliometric profile in this directory for 2025. The publisher recorded for the journal is SAGE PUBLICATIONS INC. Its listed Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor is 2.000. The five-year Journal Impact Factor is 2.300, giving a second citation window for comparison. The journal is recorded in quartile Q3 for its listed JCR category.

Category position and quartile

The recorded JCR category position is 57 out of 98 journals. Based on that rank position, the journal sits within approximately the top 58% of the listed category. Its listed quartile is Q3. Category ranks and quartiles are field-specific and are not measures of the quality of an individual article.

How the citation indicators compare

The five-year Journal Impact Factor (2.300) is 0.300 points higher than the standard Journal Impact Factor (2.000). Without journal self-citations, the Impact Factor is 1.900, a difference of 0.100 points from the listed standard value. The Journal Citation Indicator (JCI) is recorded as 0.480. These measures use different definitions or citation windows, so they are most useful when read together rather than treated as interchangeable scores.

Citation and publication counts

For 2025, the directory record for CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS lists total cites: 3,400; total articles: 118; citable items: 136. These fields describe different parts of the JCR record and should not be combined into an article-level quality score.

Citation half-life profile

The cited half-life is 5.8 years, indicating the median age of items that contributed citations to the journal in the reporting framework. The citing half-life is 6.5 years, indicating the median age of references used by the journal’s articles.

Identifiers and verification

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS is identified in this directory by print ISSN 1076-0296 and electronic ISSN 1938-2723. The publisher is recorded as SAGE PUBLICATIONS INC. When making submission, library, or research-evaluation decisions, verify the title and identifiers against the journal publisher and the official Clarivate Journal Citation Reports record.

Complete journal information

Use this table to verify the individual metric values, identifiers and publication details stored for this journal.

Journal nameCLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
Abbreviated journalCLIN APPL THROMB-HEM
PublisherSAGE PUBLICATIONS INC
Metric year2025
Overall rank8,303
ISSN1076-0296
eISSN1938-2723
Total cites3,400
Total articles118
Citable items136
Cited half-life5.8 years
Citing half-life6.5 years
JCR-based Journal Impact Factor2.000
5-Year Impact Factor2.300
Impact Factor without journal self-cites1.900
Journal Citation Indicator0.480
JCR Impact Factor quartileQ3
JCR category rank57/98
Database record updated

Frequently asked questions

What is the 2025 JCR-based Journal Impact Factor of CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS?

The Journal Impact Factor recorded in this directory as a Clarivate Journal Citation Reports (JCR)-based value for CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS is 2.000 for the 2025 metric year.

What are the JCR quartile and category rank of CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS?

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS is listed with quartile Q3 and category rank 57/98. These values are category-specific and should be verified against the official JCR record when used for formal assessment.

What is the five-year Journal Impact Factor of CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS?

The five-year Journal Impact Factor recorded for CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS is 2.300. It uses a longer citation window than the standard Journal Impact Factor.

Who publishes CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS?

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS is listed in this directory as being published by SAGE PUBLICATIONS INC.

Additional records from the same publisher or with a similar listed JCR Impact Factor.